IP Library Granted Patent US 7,169,385
Granted Patent B2
US 7,169,385 · App. 10/792,648 · Granted Jan 30, 2007

Solubilized CoQ-10 and carnitine

Assignee: Ronald G. Udell
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,169,385
App. No.
10/792,648
Granted
Jan 30, 2007
Kind
B2
Abstract

The present invention is directed to compositions and methods of delivery of CoQ-10 and an amino acid solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 and the amino acid, such as carnitine, i.e., carnitine tartrate, in formulations, such as soft gel capsules.

Claims (25)

1. A composition comprising: coenzyme Q-10 and carnitine; a sufficient quantity of limonene suitable to solubilize said coenzyme Q-10 and carnitine; and an acceptable carrier.

2. The composition of claim 1 , wherein said coenzyme Q-10 is selected from the group consisting of coenzyme Q-10, reduced coenzyme Q-10 and semi-reduced coenzyme Q-10.

3. The composition of claim 1 , wherein said composition is in the form of a solution, an elixir, a suspension, or a caplet.

4. The composition of claim 3 , wherein said caplet is a soft gelatin tablet or capsule.

5. The composition of claim 4 , wherein said soft gelatin tablet or capsule further comprises rice bran oil or beeswax.

6. The composition of claim 1 , wherein said coenzyme Q-10 is solubilized in an amount of at least about 0.1% by weight to about 45% by weight.

7. The composition of claim 6 , wherein said coenzyme Q-10 is solubilized in an amount of least about 5% to about 40% by weight.

8. The composition of claim 1 , wherein said carnitine is solubilized in an amount of at least about 0.1% by weight to about 20% by weight.

9. The composition of claim 8 , wherein said carnitine is solubilized in an amount of at least about 0.5% by weight to about 10% by weight.

10. The composition of claim 1 , further comprising vitamin E.

11. The composition of claim 1 , further comprising a seed oil.

12. The composition of claim 1 , further comprising a fish oil.

13. The composition of claim 1 , further comprising an antioxidant.

14. The composition of claim 4 , wherein said soft gelatin tablet or capsule further comprises an antioxidant.

15. A packaged nutraceutical formulation comprising: coenzyme Q-10 and carnitine, and a sufficient quantity of limonene, wherein said formulation is encapsulated in a gelatin capsule, and instructions for use thereof.

16. The packaged nutraceutical formulation of claim 15 , wherein said coenzyme Q-10 is selected from the group consisting of coenzyme Q-10, reduced coenzyme Q-10 and semi-reduced coenzyme Q-10.

17. The packaged nutraceutical formulation of claim 15 , wherein said carnitine is solubilized in an amount of at least about 0.1% by weight to about 20% by weight.

18. The packaged nutraceutical formulation of claim 17 , wherein said carnitine is solubilized in an amount of at least about 0.5 % by weight to about 10 % by weight.

19. The composition of claim 4 , wherein said coenzyme Q-10 is solubilized in an amount of at least about 0.1% by weight to about 45% by weight.

20. The composition of claim 19 , wherein said coenzyme Q-10 is solubilized in an amount of least about 5% to about 40% by weight.

21. The composition of claim 4 , wherein said carnitine is solubilized in an amount of at least about 0.1% by weight to about 20% by weight.

22. The composition of claim 21 , wherein said carnitine is solubilized in an amount of at least about 0.5% by weight to about 10% by weight.

23. The packaged nutraceutical formulation of claim 15 , wherein said gelatin capsule is a soft gelatin capsule.

24. The packaged nutraceutical formulation of claim 15 , wherein said coenzyme Q-10 is solubilized in an amount of at least about 0.1% by weight to about 45% by weight.

25. The packaged nutraceutical formulation of claim 15 , wherein said coenzyme Q-10 is solubilized in an amount of at least about 0.5% by weight to about 40% by weight.

Assignments (6)
ASSIGNMENT OF IP SECURITY AGREEMENT Recorded Aug 6, 2009
From: TEXTRON FINANCIAL CORPORATION
To: WELLS FARGO BANK, N.A., AS AGENT
Reel/Frame 023056/0680 →
COLLATERAL ASSIGNMENT AND SECURITY AGREEMENT Recorded Aug 27, 2007
From: SOFT GEL TECHNOLOGIES, INC.
To: TEXTRON FINANCIAL CORPORATION
Reel/Frame 019744/0754 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2006
From: UDELL, RONALD G.
To: SOFT GEL TECHNOLOGIES, INC.
Reel/Frame 018530/0863 →
SECURITY AGREEMENT Recorded Oct 17, 2006
From: SOFT GEL TECHNOLOGIES, INC.
To: THE CIT GROUP/CREDIT FINANCE, INC.
Reel/Frame 018398/0068 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2005
From: SOFT GEL TECHNOLOGIES, INC.
To: UDELL, RONALD G.
Reel/Frame 015618/0462 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2004
From: FANTUZZI, MICHAEL; UDELL, RONALD G.
To: SOFT GEL TECHNOLOGIES, INC.
Reel/Frame 015514/0377 →
Continuity (2)
Continuation In Part 1067426800 · Sep 29, 2003
Related Publication 20050079164A1 · Apr 14, 2005